Clinical Pharmacokinetics of Amiodarone
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Amiodarone is an iodinated benzofuran derivative with recognised antiarrhythmic activity in man. As yet, its pharmacokinetic behaviour has not been satisfactorily characterised. Specific and sensitive high-pressure liquid chromatographic methods have become available only recently and this partly explains the scarcity of pharmacokinetic data on the drug. Available evidence suggests that absorption of amiodarone following oral administration is erratic and unpredictable; oral bioavailability ranges from 22 to 86%. The drug is eliminated largely by metabolism; less than 1% of the dose is excreted unchanged in the urine. Biliary excretion may have a role in the overall elimination of the drug. Desethyl-amiodarone is the only metabolite positively identified in the plasma of patients receiving treatment with amiodarone; no data are available on its possible pharmacological activity. Since it is a highly lipophilic drug, amiodarone is extensively distributed into tissues. Adipose tissue and skeletal muscle accumulate large amounts of the drug during long term treatment. Myocardium/plasma ratios of amiodarone are high both in man and in animals; peak concentrations in the myocardium are reached within half an hour after administration of an intravenous bolus to dogs. Placental transfer of amiodarone has been demonstrated in humans, while its blood profile is not modified by dialysis treatment. In vitro protein binding of amiodarone has been reported to be 96.3 +/- 0.6%. The plasma half-life of amiodarone after single-dose administration has been reported to be in the range of 3.2 to 79.7 hours. However, after withdrawal of long term amiodarone treatment the half-life is as long as 100 days. Total body clearance ranges from 0.10 to 0.77 L/min after single-dose intravenous administration, and the apparent volume of distribution ranges between 0.9 and 148 L/kg. Amiodarone disposition kinetics in patients with cardiac arrhythmias are not different from those in healthy volunteers. However, the possible effects of liver and cardiac failure on the drug's kinetics have not been studied. Amiodarone potentiates the anticoagulant effect of warfarin, probably by inhibition of its metabolism. Increases of steady-state concentrations of digoxin, together with the appearance of signs of digitalis toxicity, have been reported when amiodarone was given to patients receiving long term treatment with digoxin. Amiodarone has also been shown to interact with other antiarrhythmic agents such as quinidine and procainamide. The time of onset of action of amiodarone after a single intravenous dose ranges between 1 and 30 minutes and its duration of effect between 1 and 3 hours.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While the allometric exponent for VD commonly approximates 1.0, certain highly lipophilic or tissue-binding drugs, such as amiodarone [33] and digoxin [34], exhibit volumes that are substantially higher than predicted.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [33]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 78 · Cited by 333
Metadata
- Authors
- Latini, R., Tognoni, G., & Kates, R. E.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Venue
- Clinical Pharmacokinetics
- Published
- 1984
- Volume
- 9
- Issue
- 2
- Pages
- 136-156
- ISSN
- 0312-5963 (ISSN-L)
- OpenAlex
- W1983541140
- Cited by
- 333
- References
- 78
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 18 · 2023: 14 · 2022: 9 · 2021: 13 · 2020: 9 · 2019: 15 · 2018: 14 · 2017: 8 · 2016: 10 · 2015: 9 · 2014: 4 · 2013: 7 · 2012: 2
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacokinetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centre National de la Recherche Scientifique
- Merck Sharp and Dohme
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- amiodarone, pharmacokinetics, oral bioavailability, drug metabolism, desethylamiodarone, tissue distribution, protein binding, plasma half-life, volume of distribution, drug interactions, warfarin, digoxin, antiarrhythmic drugs, drug excretion, tissue accumulation, cardiac arrhythmias, dialysis, liver failure, heart failure, placental transfer
- MeSH terms
- Administration, Oral, Amiodarone, Animals, Benzofurans, Biological Availability, Digoxin, Dogs, Drug Interactions, Female, Humans, Injections, Intravenous, Kinetics, Maternal-Fetal Exchange, Milk, Human, Pregnancy, Rabbits, Tissue Distribution, Warfarin, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Pharmacokinetics of Amiodarone. https://app.cochat.ai/papers/10.2165/00003088-198409020-00002
- The paper
- Latini, R., Tognoni, G., & Kates, R. E. (1984). Clinical Pharmacokinetics of Amiodarone. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-198409020-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.